Funding Details
- Awarder
- Inbox
- Date Award
- April 15, 2025
- Vertical
- Biotech and Health
- Funding URL
- View Funding Page
Company Info
- Traction
- Phantom Neuro has received FDA Breakthrough Device and TAP designations, indicating significant progress in its path to commercialization.
- Founders
- Dr. Connor Glass
- Company Description
- Phantom Neuro develops muscle-machine interfaces for robotic limb rehabilitation solutions.
- Market
- Medical Technology for Amputees
- Location
-
Austin,
California,
USA
- Coinvestors
- Ottobock, Breakout Ventures, Draper Associates, LionBird Ventures, Time BioVentures, Risk and Return, Actual VC, METIS Innovative, E1 Ventures, Jumpspace, MainSheet Ventures, Brown Advisory, Johns Hopkins, Intel
Links